Deep Health AI India Ltd revises FY26 audit report

2 min read     Updated on 13 Jul 2026, 01:47 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Deep Health AI India Ltd submitted a revised audit report for FY26 to include entity names in the consolidated financial statements, confirming no change in financial results. The auditor flagged key matters regarding an exceptional loss on a proposed acquisition and the deviation in utilization of Rights Issue proceeds.

powered bylight_fuzz_icon
45476205

*this image is generated using AI for illustrative purposes only.

Deep Health AI India Ltd submitted a revised audit report for the financial year ended March 31, 2026, to the BSE. The revision incorporates the names of entities covered under the Consolidated Financial Statements, which were inadvertently omitted in the previous filing. The company clarified that there is no change in the audited standalone and consolidated financial results as a result of this update.

The Board of Directors had approved the audited standalone and consolidated financial results at its meeting held on May 29, 2026. The subsequent observation regarding the omission of entity names in the Auditor's Report prompted the filing of the revised document. The company stated that the omission was purely inadvertent and does not impact the financial results or the audit opinion.

The independent auditor, VRSK & Co. LLP, highlighted two key audit matters in the report. The first concerned accounting implications arising from a proposed acquisition of Oasis Ceramics Pvt. Ltd. under the Insolvency and Bankruptcy Code, 2016. The company recognised an exceptional loss related to the amount paid and a bank guarantee of ₹3.21 crore that was invoked due to delays in payment timelines.

The second key audit matter addressed the utilization of proceeds from a Rights Issue. The company raised ₹39.97 crore during the year but utilised only ₹2.5 crore towards the objects stated in the Letter of Offer. The balance amount of ₹37.47 crore was utilised for other purposes, primarily investment in securities, a deviation that was ratified by shareholders on January 22, 2026.

Utilization of Rights Issue Proceeds

Nature of Securities Purpose for which funds were raised Total Amount raised Amount utilized for the other purpose Unutilized balance as at the Balance sheet date Remarks
Equity Shares Acquisition of Oasis Ceramics Private Limited 30,00,000 30,00,000 0 Entire amount diverted to investment in Equity.
Equity Shares To meet General corporate purposes 9,62,760 7,61,260 0 Partially utilised; balance diverted to investment in Equity and share issue expense.
Equity Shares To meet the expenses of the Issue 35,000 0 0 Excess Utilization Rs 13.86 Lacs

The auditor affirmed that the internal financial controls over financial reporting were adequate and operating effectively as of March 31, 2026. The revised report was signed by Suresh G. Kothari, Partner at VRSK & Co. LLP, on May 29, 2026.

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-1.96%-3.38%-14.89%-62.34%-51.92%+81.82%

What is the expected timeline for the completion of the Oasis Ceramics acquisition under the Insolvency and Bankruptcy Code?

How will the significant deviation in Rights Issue proceeds utilization impact the company's ability to raise future capital?

What specific securities did the company invest the diverted ₹37.47 crore in, and what is the current valuation of those investments?

Deep Health AI EGM scheduled on 30 Jul 2026

1 min read     Updated on 07 Jul 2026, 06:16 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Deep Health AI India Ltd has scheduled an Extraordinary General Meeting (EGM) on July 30, 2026, to seek shareholder approval for the appointment of two independent directors. The meeting will be held via video conferencing at 3:00 PM IST. Shareholders can participate and vote through remote e-voting, which commences at 9:00 AM on July 27, 2026, and concludes at 5:00 PM on July 29, 2026. The cut-off date for determining eligibility is July 23, 2026.

powered bylight_fuzz_icon
44559392

*this image is generated using AI for illustrative purposes only.

Deep Health AI India Ltd has scheduled an Extraordinary General Meeting (EGM) on July 30, 2026, via video conferencing to seek shareholder approval for the appointment of two independent directors. The meeting will be held at 3:00 PM IST. Shareholders can participate and vote through remote e-voting, which commences at 9:00 AM on July 27, 2026, and concludes at 5:00 PM on July 29, 2026. The cut-off date for determining eligibility is July 23, 2026.

The board approved the draft notice for the EGM during a meeting held on July 02, 2026. The regulatory filing was submitted to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements), 2015. The company, formerly known as Deep Diamond India Limited, is headquartered at 506-509 fifth floor, Apeksha, Plot No. 256, Main Road, Hiran Magri, Sector 11, Udaipur. The filing was signed by Managing Director Narayan Singh Rathore.

Proposed Appointments

The special business includes the appointment of Mr. Bhupesh Swami (DIN: 07999261) and Mrs. Shashi Kala Dhabriya (DIN: 11611776) as Non-Executive Independent Directors. Mr. Bhupesh Swami was appointed as an Additional Director w.e.f. July 02, 2026, and his tenure, if approved, will be for two consecutive years from July 02, 2026 to July 01, 2028. Mrs. Shashi Kala Dhabriya was appointed as an Additional Director w.e.f. March 20, 2026, and her tenure, if approved, will be for five consecutive years from March 20, 2026 to March 19, 2031.

Meeting Details

Event Date Time Venue
Board Meeting July 02, 2026 05:30 PM - 08:25 PM Video Conferencing
Extraordinary General Meeting July 30, 2026 03:00 PM Video Conferencing
Remote E-Voting Start July 27, 2026 09:00 AM NSDL E-Voting System
Remote E-Voting End July 29, 2026 05:00 PM NSDL E-Voting System

Members wishing to ask questions during the EGM must register as a speaker by sending a request from their registered email address to deephealthaiindia@gmail.com by July 23, 2026, at 5:00 PM IST. Mr. Ronak Jhuthawat, Sole Proprietor of M/s. Ronak Jhuthawat & Co, has been appointed as the Scrutinizer for the remote e-voting process.

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-1.96%-3.38%-14.89%-62.34%-51.92%+81.82%

What specific expertise do Mr. Swami and Mrs. Dhabriya bring that aligns with Deep Health AI's strategic transition from its former diamond business?

How will the addition of these independent directors influence the company's governance structure and future strategic decision-making?

What are the anticipated market reactions to these board appointments, and could they signal upcoming shifts in business focus?

More News on Deep Health AI

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-51.92%